Progression of Advanced Chronic Hepatitis C (CHC): Further Follow-up Results From the Halt-C Trial

被引：0
|
作者：
Dienstag, Jules L.
Bonkovsky, Herbert L.
Kim, Hae-Young
Seeff, Leonard B.
Di Bisceglie, Adrian M.
Szabo, Gyongyi
Wright, Elizabeth C.
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
237
引用
收藏
页码：S780 / S781
页数：2
相关论文
共 50 条
  • [21] Lack of efficacy of maintenance interferon: Results of the HALT-C trial
    Bruce R. Bacon
    Current Gastroenterology Reports, 2009, 11 (1) : 1 - 2
  • [22] Evolution of the HALT-C trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders
    Lee, WM
    Dienstag, JL
    Lindsay, KL
    Lok, AS
    Bonkovsky, HL
    Shiffman, ML
    Everson, GT
    Di Bisceglie, AM
    Morgan, TR
    Ghany, MG
    Morishima, C
    Wright, EC
    Everhart, JE
    CONTROLLED CLINICAL TRIALS, 2004, 25 (05): : 472 - 492
  • [23] There is a high lifetime incidence of substance abuse but not mood disorders in hepatitis C non-responders with advanced fibrosis: Results from the HALT-C trial.
    Fontana, RJ
    Kronfol, Z
    Wright, L
    Lindsay, K
    Seeff, L
    Shiffman, M
    Di Bisceglie, A
    Bonkovsky, H
    Everson, G
    Lok, AS
    Lee, W
    Dienstag, J
    Morgan, T
    Morishima, C
    Ghany, M
    GASTROENTEROLOGY, 2002, 122 (04) : A646 - A646
  • [24] COFFEE INTAKE IS ASSOCIATED WITH LOWER RATES OF LIVER DISEASE PROGRESSION IN CHRONIC HEPATITIS C: FINDINGS FROM THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL
    Freedman, Neal D.
    Everhart, James E.
    Lindsay, Karen
    Ghany, Marc G.
    Curto, Teresa M.
    Abnet, Christian C.
    Sinha, Roshmi
    HEPATOLOGY, 2008, 48 (04) : 1101A - 1102A
  • [25] Incidence rates and risk factors associated with hepatocellular carcinoma (HCC) in patients with advanced liver disease due to hepatitis C: Results of the halt-C trial
    Lok, A. S.
    Seeff, L. B.
    Morgan, T. R.
    DiBisceglie, A. M.
    Sterling, R. K.
    Curto, T. M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S45 - S45
  • [26] Altered hepatic metabolic function in patients with chronic hepatitis C is associated with obesity, insulin resistance, or hepatic steatosis, independent of cirrhosis: Results from the HALT-C Trial
    Everson, Gregory T.
    Kulig, Clark C.
    Shiffman, Mitchell L.
    Sterling, Richard K.
    Morgan, Timothy R.
    Hoefs, John C.
    Curto, Teresa M.
    Everhart, James E.
    Wagner, David
    HEPATOLOGY, 2006, 44 (04) : 299A - 299A
  • [27] Portal hypertensive gastropathy is prevalent amongst chronic hepatitis C non-responders with bridging fibrosis and early cirrhosis: Results from the HALT-C trial.
    Fontana, RJ
    Sanyal, AJ
    Wright, E
    Di Bisceglie, A
    HEPATOLOGY, 2003, 38 (04) : 294A - 294A
  • [28] Hepatic function improves after sustained virologic response in hepatitis C patients with advanced fibrosis and cirrhosis: Results of the lead-in phase of the HALT-C trial
    Everson, GT
    Shiffman, M
    Sterling, RK
    Hoefs, JC
    Morgan, T
    DeSanto, J
    Lauriski, S
    Shea, S
    Hofmann, C
    Rietkerk, W
    Milne, N
    Wright, E
    Doherty, M
    HEPATOLOGY, 2005, 42 (04) : 697A - 697A
  • [29] Design of the halt-c trial (hepatitis C antiviral long-term treatment to prevent cirrhosis).
    Di Bisceglie, AM
    Bonkovsky, HL
    Dienstag, JL
    Everson, GT
    Lindsay, KL
    Gretch, DR
    Hoefs, JC
    Lee, WH
    Lok, AS
    Tralka, TS
    Shiffman, ML
    Wright, EC
    GASTROENTEROLOGY, 2000, 118 (04) : A1435 - A1435
  • [30] Follow-up of treated chronic hepatitis C.
    Larrey, D
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (1BIS): : S99 - S110
12345